Edgewise Therapeutics Inc. Common Stock vs StoneX Group Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while StoneX Group Inc. Common Stock trades at $59.76 (market cap $7.27B). The key difference: StoneX Group Inc. Common Stock is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, StoneX Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and StoneX Group Inc. Common Stock for 0 Days on average.
| EWTX | SNEX | |
|---|---|---|
Market Cap | $3.94B | $7.27B |
Volume | 810,104 | 1,624,795 |
Sector | Health | Financials |
52-Week High | $48.35 | $92.67 |
52-Week Low | $14.89 | $37.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $28.28B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →StoneX Group Inc. is a financial services firm providing trading, clearing, execution, and cross-border payment services to institutional, commercial, and self-directed retail clients across global markets.
Read more on SNEX →